Birmingham Research Group

Birmingham, Alabama 35216

0 studies enrolling now · 10 studies all time

What they study most

Anxiety Disorders, Binge Eating Disorder, Bipolar I Depression, Depression, Generalized Anxiety Disorder, Major Depressive Disorder

Studies at this site

• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Open Label Extension in Adults With Binge Eating Disorder (BED) — Completed
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
• A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. — Completed
• A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder — Completed
• Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Major Depressive Disorder With Mixed Features — Withdrawn before enrolling
• A Study of CX157 (TriRima) for the Treatment of Depression — Completed